NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/08/2025
Back to search
Official data from USPTO
RATIO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
14
Latest update
07/08/2025
Trademark type
Combined
Nice classes
1, 5
Filing date
10/16/2024
Registration date
07/08/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/08/2025
Last transaction
07/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/07/2022
First use in commerce
07/17/2022
Drawing code
3
Owner type
03
Owner location
Boston, MA
Examiner
LOVELACE, JAMES
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "ratio" above the word "therapeutics" with a spiral originating above the "t" in "ratio" and curling to the right of the words with a grid pattern under the spiral.
Holders and representatives
Holders
Ratio Therapeutics, Inc.
Representatives
Nicole Gage Beck Reed Riden LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Small molecule chemical structuresreagents for adhering radioactive agents to pharmaceutical compounds for chelating radioisotopes for scientific purposes; chemical agents for chelating radioisotopes.
Class 5
Radio-pharmaceutical preparations for the diagnosis and treatment of cancers; radio-pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of cancers; pharmaceutical agents that deliver a range of radioisotopes for therapeutic or diagnostic use.
Publications
History of USPTO decisions and trademark events.
14 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/20/2025
PUBO
PUBLISHED FOR OPPOSITION
05/20/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/14/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/16/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
04/16/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/16/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
04/16/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/16/2025
DOCK
ASSIGNED TO EXAMINER
04/14/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/10/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/10/2025
NWAP
NEW APPLICATION ENTERED
10/16/2024
Continuous trademark protection
Get notified about every new filing that threatens RATIO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.